|
|
We are currently investing our third fund, Care Capital Investments III, LP.
Since our founding in 2001 we have invested in the following companies.
Acura PharmaceuticalsPalatine, IL
Acura Pharmaceuticals is a specialty pharmaceutical company developing drugs
based on its innovative Aversion Technology (abuse deterrence).
Agile PharmaceuticalsPrinceton, NJ
Agile is developing a low dose, weekly contraceptive patch.
Anacor PharmaceuticalsPalo Alto, CA
Anacor Pharmaceuticals is developing novel
small-molecule therapeutics derived from its Boron chemistry platform to
treat infectious and inflammatory diseases.
ArchemixCambridge, MA
Archemix is developing a new class of therapeutics, aptamers, for
the prevention and treatment of chronic and acute diseases.
CardiokinePhiladelphia, PA
Cardiokine is developing innovative compounds for the treatment and prevention of heart failure and related cardiovascular indications.
CoLucid PharmaceuticalsRTP, NC
CoLucid Pharmaceuticals is developing therapies for central nervous system disorders, in particular, the treatment of migraine.
D-PharmRehovot, Israel
D-Pharm designs and develops innovative drugs for the treatment of brain disorders.
Edusa PharmaceuticalsPrinceton, NJ
Edusa Pharmaceuticals is developing a compound to treat gastroesophageal
reflux disease.
Elevation PharmaceuticalsSan Diego, CA
Elevation Pharmaceuticals is developing a pipeline of
improved aerosol drug products for chronic obstructive pulmonary disease (COPD).
Epigenesis PharmaceuticalsCranbury, NJ
Epigenesis Pharmaceuticals is developing an inhaled steroid for use in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Inotek PharmaceuticalsBerkeley, CA
Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company developing therapies with novel mechanisms of action to address significant diseases of the eye.
Medical Present ValueAustin, TX
Medical Present Value helps medical groups to improve medical practice billing by automating eligibility verification, improving billing accuracy and monitoring payor contract compliance.
MicroCHIPSBedford, MA
MicroCHIPS is pioneering intelligent implanted devices for use in chronic conditions that require careful monitoring and precise therapy.
Minerva NeurosciencesCambridge, MA
Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat central nervous system (CNS) diseases.
NephroGenexPrinceton, NJ
NephroGenex is developing a product to slow the progression of diabetic nephropathy.
NormOxysWellesley, MA
NormOxys is developing an innovative product that has the potential to treat cancer and cardiovascular diseases.
PHT CorporationCharlestown, MA
PHT Corporation is a market-leading provider of electronic patient reported outcome solutions used in clinical trials around the world.
Resolvyx PharmaceuticalsBedford, MA
Resolvyx Pharmaceuticals is developing a new class of medicines called Resolvins -- naturally-occurring, small molecule lipid mediators -- with the potential to treat a wide range of inflammatory diseases.
Sentinella Pharmaceuticals
Sentinella Pharmaceuticals develops novel antibiotics for serious infections
caused by multi-drug resistant gram positive bacteria.
Somnus TherapeuticsBedminster, NJ
Somnus Therapeutics is developing an improved therapeutic to address an important need of insomnia patients preventing middle-of-the-night awakenings while minimizing next-day effects.
VaxartSan Francisco, CA
Vaxart is a vaccine development company with novel
technology for oral vaccination against infectious agents.
|
